UTAH MEDICAL PRODUCTS INC (UTMD) Stock Price & Overview

NASDAQ:UTMDUS9174881089

Current stock price

70.22 USD
-0.43 (-0.61%)
Last:

The current stock price of UTMD is 70.22 USD. Today UTMD is down by -0.61%. In the past month the price increased by 8.65%. In the past year, price increased by 34.08%.

UTMD Key Statistics

52-Week Range51.26 - 71.805
Current UTMD stock price positioned within its 52-week range.
1-Month Range60.9 - 71.805
Current UTMD stock price positioned within its 1-month range.
Market Cap
224.002M
P/E
20.18
Fwd P/E
N/A
EPS (TTM)
3.48
Dividend Yield
1.78%

UTMD Stock Performance

Today
-0.61%
1 Week
+4.57%
1 Month
+8.65%
3 Months
+14.64%
Longer-term
6 Months +16.20%
1 Year +34.08%
2 Years +6.07%
3 Years -25.96%
5 Years -19.53%
10 Years +4.96%

UTMD Stock Chart

UTAH MEDICAL PRODUCTS INC / UTMD Daily stock chart

UTMD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to UTMD. When comparing the yearly performance of all stocks, UTMD is one of the better performing stocks in the market, outperforming 78.92% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

UTMD Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to UTMD. UTMD gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UTMD Earnings

Next Earnings DateApr 28, 2026
Last Earnings DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

UTMD Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

UTMD Groups

Sector & Classification

UTMD Financial Highlights

Over the last trailing twelve months UTMD reported a non-GAAP Earnings per Share(EPS) of 3.48. The EPS decreased by -11.94% compared to the year before.


Income Statements
Revenue(TTM)38.52M
Net Income(TTM)11.29M
Industry RankSector Rank
PM (TTM) 29.3%
ROA 9.21%
ROE 9.46%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-6.38%
Sales Q2Q%-1.23%
EPS 1Y (TTM)-11.94%
Revenue 1Y (TTM)-5.83%

UTMD Ownership

Ownership
Inst Owners69.87%
Shares3.19M
Float2.96M
Ins Owners7.18%
Short Float %4.44%
Short Ratio8.65

About UTMD

Company Profile

UTMD logo image Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Company Info

IPO: 1982-12-01

UTAH MEDICAL PRODUCTS INC

7043 S 300 West

Midvale UTAH 84047 US

CEO: Kevin L. Cornwell

Employees: 155

UTMD Company Website

UTMD Investor Relations

Phone: 18015215301

UTAH MEDICAL PRODUCTS INC / UTMD FAQ

What does UTAH MEDICAL PRODUCTS INC do?

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.


What is the stock price of UTAH MEDICAL PRODUCTS INC today?

The current stock price of UTMD is 70.22 USD. The price decreased by -0.61% in the last trading session.


Does UTMD stock pay dividends?

UTAH MEDICAL PRODUCTS INC (UTMD) has a dividend yield of 1.78%. The yearly dividend amount is currently 1.22.


What is the ChartMill rating of UTAH MEDICAL PRODUCTS INC stock?

UTMD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How many employees does UTAH MEDICAL PRODUCTS INC have?

UTAH MEDICAL PRODUCTS INC (UTMD) currently has 155 employees.


What is UTAH MEDICAL PRODUCTS INC worth?

UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of 224.00M USD. This makes UTMD a Micro Cap stock.


Who owns UTAH MEDICAL PRODUCTS INC?

You can find the ownership structure of UTAH MEDICAL PRODUCTS INC (UTMD) on the Ownership tab.